Decoy Therapeutics shareholders approve 2026 equity plan and reverse stock split

Decoy Therapeutics Inc.

Approved 2026 Equity Incentive Plan: 351,837 for, 68,978 against, 55,703 abstentions.
Approved reverse stock split of common stock at ratio between 1:4 and 1:15, at board's discretion.
Reverse split proposal: 2,187,125 votes for, 507,474 against, 2,173 abstentions.
Adjournment proposal was unnecessary due to sufficient votes; broker non-votes totaled 2,220,254.

item 5.07

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-068813
form_type: 8-K
ticker: DCOY
cik: 0001615219
company_name: Decoy Therapeutics Inc.
filed_at: 2026-02-25T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.646680+00:00
generated_at: 2026-05-16T00:19:12.916562+00:00
sec_items: ["5.07"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-068813
json_url: https://secwatch.observer/filing/0001193125-26-068813.json
markdown_url: https://secwatch.observer/filing/0001193125-26-068813.md
text_url: https://secwatch.observer/filing/0001193125-26-068813.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1615219/000119312526068813/0001193125-26-068813-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1615219/000119312526068813/dcoy-20260224.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-068813

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.